Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA, Marder SR, Mintz J.

Magn Reson Imaging. 1999 Feb;17(2):213-22.

PMID:
10215476
2.

Four-year follow-up of adrenal-to-brain transplants in Parkinson's disease.

Diamond SG, Markham CH, Rand RW, Becker DP, Treciokas LJ.

Arch Neurol. 1994 Jun;51(6):559-63.

PMID:
8198466
3.

Double-blind trial of pergolide for Parkinson's disease.

Diamond SG, Markham CH, Treciokas LJ.

Neurology. 1985 Mar;35(3):291-5.

PMID:
3883232
4.

A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.

Diamond SG, Markham CH, Treciokas LJ.

Ann Neurol. 1978 Mar;3(3):267-72.

PMID:
352236
5.

Parkinson's disease and levodopa. A five-year follow-up and review.

Markham CH, Treciokas LJ, Diamond SG.

West J Med. 1974 Sep;121(3):188-206. Review. No abstract available.

6.

Carbidopa in Parkinson disease and in nausea and vomiting of levodopa.

Markham C, Diamond SG, Treciokas LJ.

Arch Neurol. 1974 Aug;31(2):128-33. No abstract available.

PMID:
4834974
7.

One to two year treatment of Parkinson's disease with levodopa.

Treciokas LJ, Ansel RD, Markham CH.

Calif Med. 1971 May;114(5):7-14.

8.

The clinical use of levodopa in the treatment of Parkinson's disease.

McDowell FH, Markham CH, Lee JE, Treciokas LJ, Ansel RD.

Contemp Neurol Ser. 1971;8:175-201. No abstract available.

PMID:
4950056
9.

Acyanotic levocardia.

ROSENBAUM HD, PELLEGRINO ED, TRECIOKAS LJ.

Circulation. 1962 Jul;26:60-72. No abstract available.

PMID:
14493925
10.

The effect of "oxygen poisoning" on the alveolar cell mitochondria as revealed by electron microscopy.

TRECIOKAS LJ.

Aerosp Med. 1959 Sep;30:674-7. No abstract available.

PMID:
13839241

Supplemental Content

Loading ...
Support Center